Skip to menu Skip to content Skip to footer

2022

Conference Publication

Trimethoprim and sulphathiazole pharmacokinetic evaluation in adult kidney transplant recipients.

Scuderi, C., Jahan, S., Parker, S., Wallis, S., Jacks, M., John, G., McWhinney, B., Ungerer, J., Mallett. A., Healy, H., Roberts, J. and Staatz, C. (2022). Trimethoprim and sulphathiazole pharmacokinetic evaluation in adult kidney transplant recipients.. Society of Hospital Pharmacists of Australia conference, Adelaide, SA, Australia, 24-26 February 2022. Hoboken, NJ, United States: Wiley.

Trimethoprim and sulphathiazole pharmacokinetic evaluation in adult kidney transplant recipients.

2021

Conference Publication

Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant patients

Scuderi, C.E., Jahan, S., Parker, S. L., Jacks, M., John, G., McWhinney, B., Ungerer, J., Mallett, A., Healy, H., Roberts, J.A. and Staatz, C. E. (2021). Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant patients. Australian and New Zealand Society of Nephrology conference, Online, September 2021.

Trimethoprim-sulfamethoxazole pharmacokinetic evaluation in adult kidney transplant patients

2021

Conference Publication

Effect of amoxicillin on oral microcosms in a dynamic reactor

Sulugodu Ramachandra, Srinivas, Sime, Fekade, Naicker, Saiyuri, Han, Pingping, Lee, Ryan, Roberts, Jason and Ivanovski, Sašo (2021). Effect of amoxicillin on oral microcosms in a dynamic reactor. 2021 IADR/AADR/CADR General Session (Virtual Experience), Virtual, 21 July 2021. Alexandria, VA, United States: IADR.

Effect of amoxicillin on oral microcosms in a dynamic reactor

2020

Conference Publication

Pharmacodynamic evaluation of intermittent versus prolonged infusion dosing regimens of piperacillin/tazobactam in a hollow-fiber infection model against two susceptible Klebsiella pneumoniae clinical isolates

Sumi, Chandra Datta, B.Sime, Fekade, Heffernan, Aaron J., Naicker, Saiyuri, Islam, Kamrul, Cottrell, Kyra, Harris, Patrick N.A. and Roberts, Jason A. (2020). Pharmacodynamic evaluation of intermittent versus prolonged infusion dosing regimens of piperacillin/tazobactam in a hollow-fiber infection model against two susceptible Klebsiella pneumoniae clinical isolates. Federation of Infection Societies Conference 2019, Edinburgh, United Kingdom, 11-14 November 2019. London, United Kingdom: The Microbiology Society. doi: 10.1099/acmi.fis2019.po0103

Pharmacodynamic evaluation of intermittent versus prolonged infusion dosing regimens of piperacillin/tazobactam in a hollow-fiber infection model against two susceptible Klebsiella pneumoniae clinical isolates

2020

Conference Publication

The DECISIVE study: defining beta-lactam concentration in intensive care unit patients – the pharmacokinetics of piperacillin and meropenem in critically ill patients with conserved renal function

Abdul-Aziz, M., Rozali, M., Othman-Jailani, M., Rahman, A. Abd, Sulaiman, H., Atiya, N., Adiraju, S., Wallis, S., Mat, W. Wan, Mazlan, M., Jamaluddin, M., Hasan, M., Mat-Nor, M. and Roberts, J. (2020). The DECISIVE study: defining beta-lactam concentration in intensive care unit patients – the pharmacokinetics of piperacillin and meropenem in critically ill patients with conserved renal function. 31st ICC - 4th GCCMID 2019, Dubai, United Arab Emirates, 6 - 9 November 2019. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.jiph.2020.01.129

The DECISIVE study: defining beta-lactam concentration in intensive care unit patients – the pharmacokinetics of piperacillin and meropenem in critically ill patients with conserved renal function

2020

Conference Publication

Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients.

Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients. . RBWH Symposium, Brisbane, QLD Australia, 7-11 December 2020.

Interest in possible alternative methods to venepuncture-based monitoring in kidney transplant patients.

2020

Conference Publication

The burden of venepuncture for kidney transplant patients and interest in possible solutions.

Scuderi, C., Parker, S., John, G., McWhinney, B., Ungerer, J., Mallett, A., Roberts, J., Healy, H. and Staatz, C.E. (2020). The burden of venepuncture for kidney transplant patients and interest in possible solutions. . Society of Hospital Pharmacists of Australia, Online, 21-22 November 2020.

The burden of venepuncture for kidney transplant patients and interest in possible solutions.

2019

Conference Publication

Optimize cefepime dosing in critically ill patients receiving continuous venovenous hemofiltration

Lin, Hsin, Boidin, Clement, Evans, Danielle, Lopez, Natasha, Healy, Daniel, Serpico, Elena, Goutelle, Sylvain and Roberts, Jason (2019). Optimize cefepime dosing in critically ill patients receiving continuous venovenous hemofiltration. 48th Critical Care Congress of the Society-of-Critical-Care-Medicine, San Diego, CA, United States, 17-20 February 2019. Philadelphia, PA, United States: Lippincott Williams & Wilkins.

Optimize cefepime dosing in critically ill patients receiving continuous venovenous hemofiltration

2019

Conference Publication

Amikacin loading dose in critically ill patients: designing optimal dosing regimens based on stochastic control

Boidin, C., Bourguignon, L., Cohen, S., Roger, C., Lefrant, J. Y., Roberts, J. A., Allaouchiche, B., Lepape, A., Friggeri, A. and Goutelle, S. (2019). Amikacin loading dose in critically ill patients: designing optimal dosing regimens based on stochastic control. Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, Lyon, France, 12–14 June 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Amikacin loading dose in critically ill patients: designing optimal dosing regimens based on stochastic control

2019

Conference Publication

Pharmacokinetic dose-approximation significantly increases pharmacokinetic target attainment during the first 24 h of treatment with continuously infused Piperacillin/Tazobactam in critically ill patients

Richter, D. C., Frey, O., Roehr, A., Roberts, J. A., Koeberer, A., Fuchs, Th, Brenner, T., Lichtenstein, C., Weigand, M. A. and Brinkmann, A. (2019). Pharmacokinetic dose-approximation significantly increases pharmacokinetic target attainment during the first 24 h of treatment with continuously infused Piperacillin/Tazobactam in critically ill patients. 9th International Congress ‘‘Sepsis and Multiorgan Dysfunction’’, Weimar, Germany, 11–13 September 2019. Heidelberg, Germany: Springer.

Pharmacokinetic dose-approximation significantly increases pharmacokinetic target attainment during the first 24 h of treatment with continuously infused Piperacillin/Tazobactam in critically ill patients

2019

Conference Publication

Therapeutic drug monitoring -guided continuous infusion of Piperacillin/Tazobactam significantly improves pharmacokinetic target-attainment in critically ill patients: a retrospective analysis from four years of clinical experience

Richter, D. C., Frey, O., Rohr, A., Roberts, J. A., Koeberer, A., Fuchs, Th, Brenner, T., Lichtenstein, C., Weigand, M. A. and Brinkmann, A. (2019). Therapeutic drug monitoring -guided continuous infusion of Piperacillin/Tazobactam significantly improves pharmacokinetic target-attainment in critically ill patients: a retrospective analysis from four years of clinical experience. 9th International Congress ‘‘Sepsis and Multiorgan Dysfunction’’, Weimar, Germany, 11–13 September 2019. Heidelberg, Germany: Springer.

Therapeutic drug monitoring -guided continuous infusion of Piperacillin/Tazobactam significantly improves pharmacokinetic target-attainment in critically ill patients: a retrospective analysis from four years of clinical experience

2019

Conference Publication

Amikacin loading dose in critically ill patients: development of a non-parametric population pharmacokinetic model

Boidin, C., Bourguignon, L., Cohen, S., Roger, C., Lefrant, J. Y., Roberts, J. A., Allaouchiche, B., Lepape, A., Friggeri, A. and Goutelle, S. (2019). Amikacin loading dose in critically ill patients: development of a non-parametric population pharmacokinetic model. Annual Meeting of French Society of Pharmacology and Therapeutics, and INSERM Clinical Research Centers (CIC) Meeting, Lyon, France, 12–14 June 2019. Chichester, West Sussex United Kingdom: Wiley-Blackwell.

Amikacin loading dose in critically ill patients: development of a non-parametric population pharmacokinetic model

2018

Conference Publication

Does Cefazolin Prophylaxis During Elective Bariatric Caesarean Section Achieve Therapeutic Concentrations in Plasma and Interstitial Fluid?

Christensen, R., Eley, V. A., Smith, M., Jackson, D., Ryan, R., van Zundert, A., Wallis, S., Lipman, J. and Roberts, J. (2018). Does Cefazolin Prophylaxis During Elective Bariatric Caesarean Section Achieve Therapeutic Concentrations in Plasma and Interstitial Fluid?. The National Scientific Congress of the Australian Society of Anaesthetists, Perth Convention and Exhibition Centre, Perth, Western Australia, 7-10th October 2017. New South Wales, Australia: Australian Society of Anaesthetists.

Does Cefazolin Prophylaxis During Elective Bariatric Caesarean Section Achieve Therapeutic Concentrations in Plasma and Interstitial Fluid?

2018

Conference Publication

Does dosing of piperacillin-tazobactam in critically ill patients on ECMO need to change? A pharmacokinetics study

Cheng, V., Shekar, K., Abdul-Aziz, M.H., Buscher, H., Corley, A., Diehl, A., Gilder, E., Jarrett, P., Lye, I., McGuinness, S., Parke, R., Pellegrino, V., Reynolds, C., Wallis, S. C., Welch, S., Zacharias, D., Fraser, J. F. and Roberts, J. A. (2018). Does dosing of piperacillin-tazobactam in critically ill patients on ECMO need to change? A pharmacokinetics study. European Society of Intensive Care Medicine Annual Congress, Paris, France, 20-24 October 2018. Heidelberg, Germany: Springer.

Does dosing of piperacillin-tazobactam in critically ill patients on ECMO need to change? A pharmacokinetics study

2018

Conference Publication

Does dosing of ceftriaxone in critically ill patients on ECMO need to change? A pharmacokinetics study

Cheng, V., Shekar, K., Abdul-Aziz, M. H., Buscher, H., Corley, A., Diehl, A., Gilder, A., Jarrett, P., Lye, I., McGuinness, S., Parke, R., Pellegrino, V., Reynolds, C., Wallis, S. C., Welch, S., Zacharias, D., Fraser, J. F. and Roberts, J. A. (2018). Does dosing of ceftriaxone in critically ill patients on ECMO need to change? A pharmacokinetics study. European Society of Intensive Care Medicine Annual Congress, Paris, France, 20-24 October 2018. Heidelberg, Germany: Springer.

Does dosing of ceftriaxone in critically ill patients on ECMO need to change? A pharmacokinetics study

2018

Conference Publication

Does Cefazolin Prophylaxis During Elective Bariatric Surgery Achieve Therapeutic Concentrations in Plasma and Interstitial Fluid?

Ryan, R., Jackson, D. , Eley, V. A., Christensen, R., van Zundert, A ., Wallis, S., Lipman, J. and Roberts, J. (2018). Does Cefazolin Prophylaxis During Elective Bariatric Surgery Achieve Therapeutic Concentrations in Plasma and Interstitial Fluid?. The National Scientific Congress of the Australian Society of Anaesthetists, Perth Convention and Exhibition Centre, Perth, Western Australia, 7-10th October. New South Wales, Australia: The Australian Society of Anaesthetists.

Does Cefazolin Prophylaxis During Elective Bariatric Surgery Achieve Therapeutic Concentrations in Plasma and Interstitial Fluid?

2017

Conference Publication

Potential posaconazole sequestration during extracorporeal membrane oxygentation: Results from an ex-vivo experiment

Lyster, H., Pitt, T., Maunz, O., Saez, D. Garcia, Tiller, J., Leaver, N., Roberts, J., Shekar, K., Brown, D., Mills, J., Carby, M., Simon, A. and Reed, A. (2017). Potential posaconazole sequestration during extracorporeal membrane oxygentation: Results from an ex-vivo experiment. 37th Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation (ISHLT), San Diego, CA United States, 5-8 April 2017. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2017.01.055

Potential posaconazole sequestration during extracorporeal membrane oxygentation: Results from an ex-vivo experiment

2016

Conference Publication

Optimization of anti-infective Therapy by Concentration Determination Meropenem Pharmacokinetics in critically ill patients undergoing sustained low-efficiency dialysis (SLED)

Koenig, C., Braune, S. A., Roberts, J. A., Nierhaus, A., Steinmetz, O. M., Baehr, M., Neely, M., Langebrake, C. and Kluge, S. (2016). Optimization of anti-infective Therapy by Concentration Determination Meropenem Pharmacokinetics in critically ill patients undergoing sustained low-efficiency dialysis (SLED). Gemeinsamen Jahrestagung der DGIIN und ÖGIAIN. Der Mensch – ein anspruchsvoller Arbeitsplatz, Berlin, Germany, 8-10 June 2016. Heidelberg, Germany: Springer.

Optimization of anti-infective Therapy by Concentration Determination Meropenem Pharmacokinetics in critically ill patients undergoing sustained low-efficiency dialysis (SLED)

2015

Conference Publication

Can therapeutic drug monitoring optimise exposure of piperacillin in febrile neutropenic patients with haematological malignancies? A randomised controlled trial

Sime, F. B., Roberts, M., Tiong, I. S., Gardner, J., Lehman, S., Peake, S., Hahn, U., Warner, M. and Roberts, J. (2015). Can therapeutic drug monitoring optimise exposure of piperacillin in febrile neutropenic patients with haematological malignancies? A randomised controlled trial. 20th Congress of European Hematology Association, Vienna, Austria, 11-14 June 2015. Pavia, Italy: Fondazione Ferrata Storti.

Can therapeutic drug monitoring optimise exposure of piperacillin in febrile neutropenic patients with haematological malignancies? A randomised controlled trial

2015

Conference Publication

The BLISS Study: Beta-Lactam Infusion in Severe Sepsis- Randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting

Abdul-Aziz, M. H., Sulaiman, H., Mat-Nor, M., Rai, V., Wong, K., Hasan, M., Wallis, S., Lipman, J., Staatz, C. E. and Roberts, J. (2015). The BLISS Study: Beta-Lactam Infusion in Severe Sepsis- Randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting. Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), San Diego, CA United States, 17-21 September 2015.

The BLISS Study: Beta-Lactam Infusion in Severe Sepsis- Randomised controlled trial of continuous versus intermittent beta-lactam infusion in critically ill patients with severe sepsis in a Malaysian ICU setting